Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2021-12-29 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
CIRCULAR FOR THE FIRST EXTRAORDINARY GENERAL MEETING AND THE FIRST H SHARES CLASS MEETING OF 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by Pharmaron Beijing Co., Ltd. containing detailed information about proposed corporate actions including repurchase and cancellation of shares, reduction of registered capital, amendments to articles of association and internal rules, appointment of internal control auditor, and notices of extraordinary general meeting (EGM) and class meetings. It includes a letter from the board, definitions, and appendices with procedural rules. The document is comprehensive and intended to inform shareholders to make decisions at the upcoming EGM and class meetings. It is not a financial report, earnings release, or audit report, nor is it a simple announcement or proxy solicitation. The content aligns with materials typically provided in a Proxy Solicitation & Information Statement, which provides detailed information to shareholders to solicit votes for meeting resolutions. Therefore, the document is best classified as a Proxy Solicitation & Information Statement (PSI).
2021-12-29 English
NOTICE OF THE FIRST H SHARES CLASS MEETING OF 2022
Regulatory Filings Classification · 95% confidence The document is a notice for the first H Shares Class Meeting of 2022 for Pharmaron Beijing Co., Ltd. It details the meeting date, location, agenda items (repurchase and cancellation of shares, reduction of registered capital), voting procedures, proxy appointment instructions, and closure of the register of members. It is an announcement informing shareholders about the upcoming class meeting and related procedural details. There is no financial data, no report content, no voting results, and no management or board changes disclosed. The document is not a report itself but a notice of a shareholder meeting. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of a class meeting with resolutions to be voted on, and not the solicitation materials or proxy forms themselves, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the meeting and voting procedures without actual voting results or proxy solicitation materials. The document length (6277 characters) and content confirm it is a formal announcement of a meeting rather than a report or results announcement.
2021-12-29 English
NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2022
Regulatory Filings Classification · 95% confidence The document is a notice for the first Extraordinary General Meeting (EGM) of 2022 for Pharmaron Beijing Co., Ltd. It includes details about the meeting date, location, agenda items (special and ordinary resolutions), closure of register of members, proxy appointment instructions, and other procedural notes. There is no financial data, earnings information, or report content. The document is clearly an announcement of a shareholder meeting rather than a report or results announcement. Therefore, it fits the category of a meeting notice, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since this is a notice of the meeting itself (not the voting results or proxy materials), it is best classified as a Regulatory Filing (RNS) because the exact category for meeting notices is not listed separately, and RNS is the fallback for such regulatory announcements that do not fit other categories. The document length is over 7000 characters, so it is not a brief announcement but a full notice. Hence, the best classification is Regulatory Filings (RNS).
2021-12-29 English
CLOSURE OF REGISTER OF MEMBERS FOR THE FIRST EXTRAORDINARY GENERAL MEETING OF 2022 AND THE FIRST H SHARES CLASS MEETING OF 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement regarding the closure of the register of members for the purpose of determining shareholders entitled to attend and vote at an Extraordinary General Meeting (EGM) and a Class Meeting. It specifies dates for the register closure and instructions for share transfers to be eligible for voting. It also mentions that the announcement and circular with details of resolutions and notices will be sent to shareholders in due course. The document is short (2823 characters) and does not contain any financial data, results, or detailed reports. It is clearly an announcement related to shareholder meeting logistics rather than the meeting materials or results themselves. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Regulatory Filings (RNS). However, since it is about the closure of the register for voting eligibility ahead of a meeting, it is more aligned with voting rights announcements. Hence, the classification is DVA with high confidence.
2021-12-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2021-12-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2021-12-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.